Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-038294·Alpha Tau Medical Ltd.
Schedule 13D ownership disclosure
ALPHA TAU MEDICAL LTD
Ordinary shares, no par value · CUSIP: M0740A108
Event date: 2025-04-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Oramed Pharmaceuticals Inc.Reported CIK 0001176309
Shares: 14,110,121.00 · Class: 19.99%
- Oramed Ltd.
Shares: 14,110,121.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-038294
- Form type
- SCHEDULE 13D
- Filer
- Alpha Tau Medical Ltd.
- CIK
- CIK 1871321
- Filed
- May 01, 2025
- Reporting period
- Apr 24, 2025
- Description
- Schedule 13D beneficial ownership